GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changchun BCHT Biotechnology Co (SHSE:688276) » Definitions » Change In Receivables

Changchun BCHT Biotechnology Co (SHSE:688276) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Changchun BCHT Biotechnology Co Change In Receivables?

Changchun BCHT Biotechnology Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Changchun BCHT Biotechnology Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Changchun BCHT Biotechnology Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-691 Mil. It means Changchun BCHT Biotechnology Co's Accounts Receivable increased by ¥691 Mil from Dec. 2022 to Dec. 2023 .

Changchun BCHT Biotechnology Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥1,589 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Changchun BCHT Biotechnology Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 536.50.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Changchun BCHT Biotechnology Co's liquidation value for the three months ended in Mar. 2024 was ¥689 Mil.


Changchun BCHT Biotechnology Co Change In Receivables Historical Data

The historical data trend for Changchun BCHT Biotechnology Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changchun BCHT Biotechnology Co Change In Receivables Chart

Changchun BCHT Biotechnology Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial -48.14 -418.58 -40.04 -171.36 -691.36

Changchun BCHT Biotechnology Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Changchun BCHT Biotechnology Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Changchun BCHT Biotechnology Co  (SHSE:688276) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Changchun BCHT Biotechnology Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1589.144/270.288*91
=536.50

2. In Ben Graham's calculation of liquidation value, Changchun BCHT Biotechnology Co's accounts receivable are only considered to be worth 75% of book value:

Changchun BCHT Biotechnology Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=392.479-1011.362+0.75 * 1589.144+0.5 * 232.974
=689

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Changchun BCHT Biotechnology Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Changchun BCHT Biotechnology Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Changchun BCHT Biotechnology Co (SHSE:688276) Business Description

Traded in Other Exchanges
N/A
Address
No. 1260, Huoju Road, High-tech Development Zone, Jilin Province, Changchun, CHN, 130012
Changchun BCHT Biotechnology Co is a biopharmaceutical enterprise specializing in the research and development, production and sales of human vaccines.
Executives
Shi Nian Min Core technical personnel
Jiang Chun Lai Directors, senior managers, core technical personn
Zhu Chang Lin Core technical personnel
Wei Wei Senior management, core technical personnel
Yu Bing senior management
Liu Da Wei Senior management, core technical personnel
Meng Zhao Feng senior management
Zhang Zhe senior management
Kong Wei Directors, senior managers, core technical personn
Feng Da Qiang Supervisors

Changchun BCHT Biotechnology Co (SHSE:688276) Headlines

No Headlines